glp-1 risks Drugs and Eating Disorders: A Hidden Risk in the Weight Loss Revolution – The Chicago Council on Science and Technology Glucagon-like peptide-1 receptor agonists and
Description
Three randomized controlled trials (lasting up to six months) compared olanzapine-samidorphan versus olanzapine alone in 1116 patients with schizophrenia (Srisurapanont M et al, Sci Rep 2021;11(1):7583)

No medication replaces lifestyle
Others may require episodic re-use or long-term use of GLP-1 drugs to help with weight maintenance

A consensus document put out by the American College of Sports Medicine suggests 75 minutes per week of vigorous intensity physical activity as an alternative exercise regimen

About GLP-1 Weight Loss Medications If youre interested in exploring your medical weight loss options, the team at our Louisiana weight loss clinics can help you decide if a GLP-1 medication is right for you
